MIRM (Mirum Pharmaceuticals) חוב לטווח קצר להון

Mirum Pharmaceuticals (MIRM) maintains an impeccable reputation among specialized physicians due to the development of life-saving treatments for severe liver pathologies. This price chart reflects the indicator's trend, which is currently fixed at 0.00. High financial barriers to entry and patent protection shield the business from competition. The company is currently expanding the distribution of its products, optimizing research expenses while increasing global supplies.

Mirum Pharmaceuticals (MIRM) finances the development of drugs for rare liver pathologies by reinvesting commercialization profits into new research. Analyzing the short-term debt-to-equity chart on GURU.Markets, an investor can track the daily ratio of liabilities under one year to equity, which eliminates information gaps between reports and allows for the timely identification of an overvalued asset.